Lopressor

   
Google
 
Web NewDrugInformation.com

Lopressor


Drug - Lopressor
The trade name of the product as shown on the labeling.

Dosage - TABLET, EXTENDED RELEASE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Metoprolol Fumarate
Multiple ingredients are in alphabetical order.

Strength - EQ 300MG TARTRATE
The potency of the active ingredient(s), Metoprolol Fumarate. May repeat for multiple part products.

Applicant - NOVARTIS
The firm name holding legal responsibility for Lopressor. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 019786
The FDA assigned number to Lopressor. Format is nnnnnn.

Product Number - 003
The FDA assigned number to identify Lopressor. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 27, 1989
The date Lopressor was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Lopressor. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Lopressor is in. Format is RX, OTC, DISCN.

Applicant Full Name - Novartis Pharmaceuticals Corp
The full name of the firm holding legal responsibility for the new application of Lopressor.

Lopressor